Kinjal Desai, in Nottingham, MD - Pharmacist

Kinjal Desai, is a Pharmacist based in Nottingham, Maryland. Kinjal Desai is licensed to practice in Maryland (license number 26630) and her current practice location is 5230 Campbell Blvd, Nottingham, Maryland. She can be reached at her office (for appointments etc.) via phone at (410) 933-9680.

NPI number for Kinjal Desai is 1043858194 and her current mailing address is 115 Christina Landing Dr Apt 205, Wilmington, Delaware. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1043858194.

Contact Information

	Kinjal Desai,
	5230 Campbell Blvd, Nottingham, MD 21236-4983
	(410) 933-9680
	Not Available

Healthcare Provider's Profile

Full Name	Kinjal Desai
Gender	Female
Speciality	Pharmacist
Location	5230 Campbell Blvd, Nottingham, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1043858194
Provider Enumeration Date: 12/19/2019
Last Update Date: 12/10/2020

Medical Identifiers

Medical identifiers for Kinjal Desai such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043858194	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	26630 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kinjal Desai is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kinjal Desai, 115 Christina Landing Dr Apt 205, Wilmington, DE 19801-5453 Ph: (586) 248-3002	Kinjal Desai, 5230 Campbell Blvd, Nottingham, MD 21236-4983 Ph: (410) 933-9680

News Archive

Study results presented at ASCO-GI reinforce value of Genomic Health's Oncotype DX Colon Cancer test

Genomic Health, Inc. today announced presentation of three studies at the American Society of Clinical Oncology Gastrointestinal Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score® (RS) test as well as T-stage and mismatch repair (MMR) status, should be considered by physicians during the treatment decision-making process.

Light therapy offers a safe, cost-effective alternative for treatment of neurodegenerative diseases

A lot about the human brain and its intricacies continue to remain a mystery. With the advancement of neurobiology, the pathogenesis of several neurodegenerative diseases (ND) has been uncovered to a certain extent along with molecular targets around which current therapies revolve.

New genetic risk factor for Parkinson's disease identified

An international team of doctors and human geneticists has identified a new genetic risk factor for Parkinson's disease. The institutions involved in the study were the Institute of Human Genetics of Helmholtz Zentrum München and Technische Universität München, the Neurological Clinic of Ludwig-Maximilians-Universität Munich (LMU) and the Mitochondrial Research Group of Newcastle University, Newcastle upon Tyne, UK.

European patent strengthens Soligenix' topically active steroid intellectual property portfolio

Soligenix, Inc., a late-stage biotechnology company, announced today that the European Patent Office granted patent EP 1392321 "Method of Treating Inflammatory Disorders of the Gastrointestinal Tract using Topically Active Corticosteroids." The new patent's main claims cover the use of topically active corticosteroids in orally administered dosage forms that act concurrently in the upper and lower gastrointestinal tract.

High levels of homocysteine, an amino acid in the blood, may indicate an increased risk of stroke

Observational studies measuring homocysteine concentrations in healthy individuals have found that, on average, those with high levels of homocysteine in their blood are more likely to have a stroke. But other factors that increase homocysteine concentration and stroke risk— such as smoking and socioeconomic class—may be responsible for the relationship observed in these studies, confounding the result.

Pharmacist in Nottingham, MD

Jeffrey Eugene Paup, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8905 Belair Rd, Nottingham, MD 21236 Phone: 410-256-9870 Fax: 410-256-9869
Dr. Laura Ann Maurin, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-9680 Fax: 443-425-3296
Dr. Kristy L Liddic, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8669 Belair Rd, Nottingham, MD 21236 Phone: 410-256-2844 Fax: 410-256-5376
Songe Baek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4920 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-7626
Martha M Georges, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4920 Campbell Blvd, Nottingham, MD 21236 Phone: 410-933-7626 Fax: 410-933-7669
Josni J Zacharia, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8118 Perry Hills Ct, Nottingham, MD 21236 Phone: 410-882-9943 Fax: 410-882-9947

Kinjal Desai, - Pharmacist in Nottingham, MD